RHPI:DRUG-DEVICE-TRIALS

Novo Nordisk stocks upward push as Wegovy presentations center advantages past weight reduction

FILE PHOTO: The emblem of Danish drugmaker Novo Nordisk, Copenhagen, Denmark, September 26, 2023. REUTERS/Tom Little/Record Picture Achieve Licensing RightsLONDON, Nov 13 (Reuters) – Novo Nordisk (NOVOb.CO) stocks rose 3% on Monday

November 13, 2023

OpenAI

Novo Nordisk says Wegovy coronary heart advantages because of greater than weight reduction

A zero.25 mg injection pen of Novo Nordisk’s weight-loss drug Wegovy is proven on this photograph representation in Oslo, Norway, September 1, 2023. REUTERS/Victoria Klesty/Representation/Report Photograph Gain Licensing RightsPHILADELPHIA, Nov 11 (Reuters)

November 11, 2023

Health

US FDA approves Pfizer’s inflammatory bowel illness drug

A corporate brand is observed at a Pfizer place of job in Puurs, Belgium, December 2, 2022. REUTERS/Johanna Geron/Record Picture Achieve Licensing RightsOct 13 (Reuters) – The U.S. Meals and Drug Management

October 13, 2023

Business

RHPI:DRUG-DEVICE-TRIALS

Novo Nordisk stocks upward push as Wegovy presentations center advantages past weight reduction

Novo Nordisk says Wegovy coronary heart advantages because of greater than weight reduction

US FDA approves Pfizer’s inflammatory bowel illness drug

Recent Posts

Categories

Suggestions

RHPI:DRUG-DEVICE-TRIALS

Novo Nordisk stocks upward push as Wegovy presentations center advantages past weight reduction

Novo Nordisk says Wegovy coronary heart advantages because of greater than weight reduction

US FDA approves Pfizer’s inflammatory bowel illness drug

Recent Posts

Categories